Cargando…

Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis

Brazil is the largest country in South America and the most genetically heterogeneous. The aim of the present study was to determine the prevalence of germline pathogenic variants (PVs) in Brazilian patients with breast cancer (BC) who underwent genetic counseling and genetic testing at a tertiary O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandoval, Renata Lazari, Leite, Ana Carolina Rathsam, Barbalho, Daniel Meirelles, Assad, Daniele Xavier, Barroso, Romualdo, Polidorio, Natalia, dos Anjos, Carlos Henrique, de Miranda, Andréa Discaciati, Ferreira, Ana Carolina Salles de Mendonça, Fernandes, Gustavo dos Santos, Achatz, Maria Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895369/ https://www.ncbi.nlm.nih.gov/pubmed/33606809 http://dx.doi.org/10.1371/journal.pone.0247363

Ejemplares similares

What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?
por: Leite, Ana Carolina Rathsam, et al.
Publicado: (2022)

Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers
por: Sandoval, Renata Lazari, et al.
Publicado: (2022)

Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
por: Sandoval, Renata Lazari, et al.
Publicado: (2021)

Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants
por: Gifoni, Ana Carolina Leite Vieira Costa, et al.
Publicado: (2022)

Novel Insights From the Germline Landscape of Breast Cancer in Brazil
por: Barbalho, Daniel, et al.
Publicado: (2022)

Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients
por: Côrtes, Luiza, et al.
Publicado: (2023)

Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer
por: Torrezan, Giovana T., et al.
Publicado: (2018)

Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation
por: Vidal, Amanda Ferreira, et al.
Publicado: (2021)

Number of rare germline CNVs and TP53 mutation types
por: Silva, Amanda G, et al.
Publicado: (2012)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
por: Turin, Christie G, et al.
Publicado: (2022)

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection
por: Velázquez, Carolina, et al.
Publicado: (2020)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2023)

Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance
por: Gómez, Ana Milena, et al.
Publicado: (2019)

Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer
por: Velázquez, Carolina, et al.
Publicado: (2020)

Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America
por: Manotas, María Carolina, et al.
Publicado: (2023)

Co‐occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome
por: Ferrer‐Avargues, Rosario, et al.
Publicado: (2021)

The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
por: Silva, Amanda G, et al.
Publicado: (2014)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Xeroderma Pigmentosum: Low Prevalence of Germline XPA Mutations in a Brazilian XP Population
por: Santiago, Karina Miranda, et al.
Publicado: (2015)

Usefulness of machine learning softwares to screen titles of systematic reviews: a methodological study
por: dos Reis, Ana Helena Salles, et al.
Publicado: (2023)

Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

Germline and Somatic mutations in postmenopausal breast cancer patients
por: Nagy, Tauana Rodrigues, et al.
Publicado: (2021)

Oral manifestations of hereditary nonpolyposis colorectal cancer syndrome: a family case series
por: Almeida, Fabiana Tolentino, et al.
Publicado: (2014)

Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review
por: dos Anjos, Renata Fockink, et al.
Publicado: (2016)

Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
por: Molina-Zayas, María, et al.
Publicado: (2022)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
por: Alvarez, Carolina, et al.
Publicado: (2017)

Learning impacts on elementary education students during physical and social distancing due COVID-19
por: Barbosa, Alexandre Lucas de Araújo, et al.
Publicado: (2022)

Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
por: Määttä, Kirsi M., et al.
Publicado: (2017)

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis
por: Lopes, Carlos D. H., et al.
Publicado: (2023)

Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review
por: do Amaral, Waldemar Naves, et al.
Publicado: (2020)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
por: Achatz, Maria Isabel, et al.
Publicado: (2020)

Germline large genomic alterations on 7q in patients with multiple primary cancers
por: Villacis, R. A. R., et al.
Publicado: (2017)

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
por: Wappenschmidt, Barbara, et al.
Publicado: (2020)

Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
por: Quezada Urban, Rosalía, et al.
Publicado: (2018)

CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma
por: Ben Aissa-Haj, Jihenne, et al.
Publicado: (2022)

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6ioj9p26hmthum9u296k42hi3